Multiple sclerosis Trials in Nantes, France
Conditions / Multiple sclerosis / Nantes, France
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03222973 | Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) | TERMINATED | PHASE2 |
| NCT00725985 | Oral Cladribine in Early Multiple Sclerosis (MS) | COMPLETED | PHASE3 |
| NCT01895335 | Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients | COMPLETED | PHASE4 |
| NCT03232073 | Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT02425644 | Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis | COMPLETED | PHASE3 |
| NCT00622700 | Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT00751881 | An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT00662649 | Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT00803049 | Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT01864148 | Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex | COMPLETED | PHASE2 |